TLS Prophylaxis Intermediate Risk — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Allopurinol 300 mg daily
Intermediate-risk TLS (DLBCL, moderate burden, normal baseline labs) is managed with allopurinol prophylaxis (300 mg daily, commenced 1-2 days before chemotherapy and continued for 7-10 days) plus IV hydration (2-3 L/day). Allopurinol inhibits xanthine oxidase, preventing new uric acid formation. Monitor electrolytes, uric acid, and creatinine every 6-12 hours during initial chemotherapy.
Reference: ALLG – 2024 – TLS; ASCO 2024